Harmonization of cancer and noncancer risk assessment: proceedings of a consensus-building workshop.

  title={Harmonization of cancer and noncancer risk assessment: proceedings of a consensus-building workshop.},
  author={Matthew S. Bogdanffy and George P. Daston and Elaine M. Faustman and Carole A Kimmel and Gary L. Kimmel and Jennifer G. Seed and Vanessa Vu},
  journal={Toxicological sciences : an official journal of the Society of Toxicology},
  volume={61 1},
  • M. BogdanffyG. Daston V. Vu
  • Published 1 May 2001
  • Environmental Science
  • Toxicological sciences : an official journal of the Society of Toxicology
Significant advancements have been made toward the use of all relevant scientific information in health risk assessments. This principle has been set forth in risk-assessment guidance documents of international agencies including those of the World Health Organization's International Programme on Chemical Safety, the U.S. Environmental Protection Agency, and Health Canada. Improving the scientific basis of risk assessment is a leading strategic goal of the Society of Toxicology. In recent years… 

Figures and Tables from this paper

Practical Implications of Nonlinear Effects in Risk-Assessment Harmonization

“Harmonization” attempts to reconcile contrasting assumptions under one paradigm in quantitative risk assessment by citing variability in human susceptibility as an argument against thresholds and comparing them to what is known about human biological variability in general.

Environmental Health Risk Assessment, Statistics in

Quantitative health risk assessment is a tool for making predictions about the impact of substances in the environment on health. Despite the use of scientific principles and a reliance on the most

Use of mode of action in risk assessment: past, present, and future.

  • H. Clewell
  • Medicine
    Regulatory toxicology and pharmacology : RTP
  • 2005

Systems Biology and Biomarkers of Early Effects for Occupational Exposure Limit Setting

Estimation of internal dose and response biomarkers will be a critical test of these new technologies for application in risk assessment strategies.

The adverse outcome pathway concept: a pragmatic tool in toxicology.

Use of Toxicological Data in Estimating Reference Values for Risk Assessment

This review revealed a number of data gaps and research needs, including the need for an acute and/or short-term testing protocol that can be used to set acute and shortterm reference values, and the potential effects on uncertainty factors and low-dose extrapolation.

Worth weighting for : studies on benchmark dose analysis in relation to animal ethics in toxicity testing

A purpose of chemical health risk assessment is to characterize the nature and size of the health risk associated with exposure to chemicals, including identification of a dose below which toxic



Cancer and non-cancer risk assessment: not so different if you consider mechanisms.

Risk assessment for neurotoxic effects.

The procedure is illustrated using data for neurochemical, neurohistological, and behavioral effects of methylenedioxymethamphetamine administered to rats or monkeys to illustrate how bioassay data can be used to estimate the risk of neurotoxic effects as a function of dose.

Tissue dosimetry, pharmacokinetic modeling, and interspecies scaling factors.

The development of ISFs and their applications in health risk assessments over the past 20 years are reviewed, the impact of pharmacokinetic principles in altering current perceptions of the ISFs applied in these healthrisk assessments are examined, and future directions in applying both pharmacokinetics and pharmacodynamic principles for developing ISFs are assessed.

Human variability and noncancer risk assessment--an analysis of the default uncertainty factor.

A scheme is proposed which would allow the selection of appropriate default uncertainty factors based on knowledge of the biological fate and effects of the chemical under review and the standard default value of 3.16 for kinetics will not be adequate for all routes of elimination and all groups of the population.

Benchmark dose analysis of developmental toxicity in rats exposed to boric acid.

In this analysis of the developmental toxicity observed in rats exposed to boric acid in their diet, BMD analyses have been conducted using two existing studies and it was determined that decreased fetal body weight provided the best basis for BMD calculations.

Dose-response assessments for developmental toxicity. IV. Benchmark doses for fetal weight changes.

This study examined a variety of approaches to estimating BMDs for a change in fetal weight following chemical exposure from a total of 85 developmental toxicity experiments to provide confirmation of the advantages of the BMD approach over the NOAEL in terms of the influence of dose spacing and dose selection.

Dose-rate effects of ethylene oxide exposure on developmental toxicity.

  • E. WellerN. Long L. Ryan
  • Environmental Science
    Toxicological sciences : an official journal of the Society of Toxicology
  • 1999
In risk assessment, evaluating a health effect at a duration of exposure that is untested involves assuming that equivalent multiples of concentration (C) and duration (T) of exposure have the same

Approach to assessment of risk to human health for priority substances under the Canadian environmental protection act

Abstract The Canadian Environmental Protection Act (CEPA) authorizes the Ministers of the Environment and of Health in Canada to investigate a wide variety of substances that may contaminate the

Data-derived safety factors for the evaluation of food additives and environmental contaminants.

  • A. Renwick
  • Environmental Science
    Food additives and contaminants
  • 1993
Additional safety factors are proposed to allow for the nature or severity of the toxicity and the adequacy of the database, consistent with previous evaluations and will allow the logical derivation of factors greater than either 100 or the appropriate data-derived factor.